NM_207015.3:c.1090+13383C>G
Variant names:
Variant summary
Our verdict is Benign. The variant received -12 ACMG points: 0P and 12B. BP4_StrongBA1
The NM_207015.3(NAALADL2):c.1090+13383C>G variant causes a intron change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.383 in 151,936 control chromosomes in the GnomAD database, including 11,464 homozygotes. In-silico tool predicts a benign outcome for this variant. No clinical diagnostic laboratories have submitted clinical-significance assessments for this variant to ClinVar.
Frequency
Genomes: 𝑓 0.38 ( 11464 hom., cov: 32)
Consequence
NAALADL2
NM_207015.3 intron
NM_207015.3 intron
Scores
2
Clinical Significance
Not reported in ClinVar
Conservation
PhyloP100: -2.34
Publications
2 publications found
Genes affected
NAALADL2 (HGNC:23219): (N-acetylated alpha-linked acidic dipeptidase like 2) Predicted to enable metalloexopeptidase activity. Predicted to be involved in proteolysis. Predicted to act upstream of or within response to bacterium. Located in nucleoplasm. [provided by Alliance of Genome Resources, Apr 2022]
Genome browser will be placed here
ACMG classification
Classification was made for transcript
Our verdict: Benign. The variant received -12 ACMG points.
BP4
Computational evidence support a benign effect (BayesDel_noAF=-0.92).
BA1
GnomAd4 highest subpopulation (SAS) allele frequency at 95% confidence interval = 0.484 is higher than 0.05.
Transcripts
RefSeq
Ensembl
| Gene | Transcript | HGVSc | HGVSp | Effect | Exon rank | TSL | MANE | Protein | Appris | UniProt |
|---|---|---|---|---|---|---|---|---|---|---|
| NAALADL2 | ENST00000454872.6 | c.1090+13383C>G | intron_variant | Intron 5 of 13 | 1 | NM_207015.3 | ENSP00000404705.1 | |||
| NAALADL2 | ENST00000414826.1 | n.120+81178C>G | intron_variant | Intron 1 of 6 | 1 | ENSP00000396969.1 | ||||
| NAALADL2 | ENST00000473253.5 | n.1322+13383C>G | intron_variant | Intron 5 of 10 | 2 | |||||
| NAALADL2 | ENST00000489299.5 | n.829+13383C>G | intron_variant | Intron 5 of 10 | 2 |
Frequencies
GnomAD3 genomes AF: 0.383 AC: 58142AN: 151816Hom.: 11458 Cov.: 32 show subpopulations
GnomAD3 genomes
AF:
AC:
58142
AN:
151816
Hom.:
Cov.:
32
Gnomad AFR
AF:
Gnomad AMI
AF:
Gnomad AMR
AF:
Gnomad ASJ
AF:
Gnomad EAS
AF:
Gnomad SAS
AF:
Gnomad FIN
AF:
Gnomad MID
AF:
Gnomad NFE
AF:
Gnomad OTH
AF:
We have no GnomAD4 exomes data on this position. Probably position not covered by the project.
GnomAD4 genome AF: 0.383 AC: 58176AN: 151936Hom.: 11464 Cov.: 32 AF XY: 0.382 AC XY: 28348AN XY: 74254 show subpopulations
GnomAD4 genome
AF:
AC:
58176
AN:
151936
Hom.:
Cov.:
32
AF XY:
AC XY:
28348
AN XY:
74254
show subpopulations
African (AFR)
AF:
AC:
12688
AN:
41448
American (AMR)
AF:
AC:
5058
AN:
15262
Ashkenazi Jewish (ASJ)
AF:
AC:
1436
AN:
3470
East Asian (EAS)
AF:
AC:
1180
AN:
5164
South Asian (SAS)
AF:
AC:
2412
AN:
4822
European-Finnish (FIN)
AF:
AC:
4661
AN:
10538
Middle Eastern (MID)
AF:
AC:
122
AN:
292
European-Non Finnish (NFE)
AF:
AC:
29400
AN:
67926
Other (OTH)
AF:
AC:
819
AN:
2106
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.502
Heterozygous variant carriers
0
1823
3646
5468
7291
9114
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance
Age Distribution
Genome Het
Genome Hom
Variant carriers
0
574
1148
1722
2296
2870
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
Alfa
AF:
Hom.:
Bravo
AF:
Asia WGS
AF:
AC:
1262
AN:
3478
ClinVar
Not reported inComputational scores
Source:
Name
Calibrated prediction
Score
Prediction
BayesDel_noAF
Benign
DANN
Benign
PhyloP100
Splicing
Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
Details are displayed if max score is > 0.2
Find out detailed SpliceAI scores and Pangolin per-transcript scores at
Publications
You must be logged in to view publications. This limit was set because tens of millions (!) of queries from AI bots are generated daily.